Verastem Statistics
Total Valuation
Verastem has a market cap or net worth of $324.25 million. The enterprise value is $218.82 million.
| Market Cap | 324.25M |
| Enterprise Value | 218.82M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Verastem has 87.87 million shares outstanding. The number of shares has increased by 88.82% in one year.
| Current Share Class | 87.87M |
| Shares Outstanding | 87.87M |
| Shares Change (YoY) | +88.82% |
| Shares Change (QoQ) | +14.34% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 74.03% |
| Float | 70.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.35 |
| Forward PS | 2.58 |
| PB Ratio | 3.71 |
| P/TBV Ratio | 4.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.04, with a Debt / Equity ratio of 1.05.
| Current Ratio | 3.04 |
| Quick Ratio | 2.87 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -128.65 |
Financial Efficiency
Return on equity (ROE) is -786.15% and return on invested capital (ROIC) is -100.92%.
| Return on Equity (ROE) | -786.15% |
| Return on Assets (ROA) | -59.41% |
| Return on Invested Capital (ROIC) | -100.92% |
| Return on Capital Employed (ROCE) | -106.14% |
| Weighted Average Cost of Capital (WACC) | 4.76% |
| Revenue Per Employee | $486,127 |
| Profits Per Employee | -$1.90M |
| Employee Count | 102 |
| Asset Turnover | 0.28 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.51% in the last 52 weeks. The beta is 0.27, so Verastem's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -16.51% |
| 50-Day Moving Average | 4.71 |
| 200-Day Moving Average | 6.88 |
| Relative Strength Index (RSI) | 36.96 |
| Average Volume (20 Days) | 2,524,562 |
Short Selling Information
The latest short interest is 21.21 million, so 24.14% of the outstanding shares have been sold short.
| Short Interest | 21.21M |
| Short Previous Month | 17.87M |
| Short % of Shares Out | 24.14% |
| Short % of Float | 30.13% |
| Short Ratio (days to cover) | 8.98 |
Income Statement
In the last 12 months, Verastem had revenue of $49.59 million and -$193.96 million in losses. Loss per share was -$2.41.
| Revenue | 49.59M |
| Gross Profit | 42.21M |
| Operating Income | -170.85M |
| Pretax Income | -193.96M |
| Net Income | -193.96M |
| EBITDA | -169.86M |
| EBIT | -170.85M |
| Loss Per Share | -$2.41 |
Balance Sheet
The company has $181.68 million in cash and $85.48 million in debt, with a net cash position of $96.20 million or $1.09 per share.
| Cash & Cash Equivalents | 181.68M |
| Total Debt | 85.48M |
| Net Cash | 96.20M |
| Net Cash Per Share | $1.09 |
| Equity (Book Value) | 81.78M |
| Book Value Per Share | 0.93 |
| Working Capital | 136.06M |
Cash Flow
| Operating Cash Flow | -150.95M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 997,000 |
| Net Borrowing | -1.46M |
| Free Cash Flow | -150.95M |
| FCF Per Share | -$1.72 |
Margins
| Gross Margin | 85.13% |
| Operating Margin | -344.56% |
| Pretax Margin | -391.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Verastem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -88.82% |
| Shareholder Yield | -88.82% |
| Earnings Yield | -61.57% |
| FCF Yield | -47.92% |
Analyst Forecast
The average price target for Verastem is $15.13, which is 310.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.13 |
| Price Target Difference | 310.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 105.32% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jun 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
Verastem has an Altman Z-Score of -6.97 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.97 |
| Piotroski F-Score | 2 |